#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1810495	B	Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis	Homo sapiens	17		cell-based format	Scientific Literature
2.	ALA1816171	F	Hypoglycemic activity in orally dosed female Wistar fatty rat type 2 diabetic model assessed as increase in plasma insulin level by oral glucose tolerance test	Rattus norvegicus	1		organism-based format	Scientific Literature
3.	ALA1816172	B	Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate	Homo sapiens	24		cell-based format	Scientific Literature
4.	ALA1816173	B	Inhibition of DPP4 in rat plasma incubated for 60 mins using H-lys-Ala-pNA.2HCl substrate	Rattus norvegicus	3		cell-free format	Scientific Literature
5.	ALA1816174	B	Inhibition of DPP4 in rat spleen incubated for 60 mins using H-lys-Ala-pNA.2HCl substrate	Rattus norvegicus	3		tissue-based format	Scientific Literature
6.	ALA1816175	B	Inhibition of bovine spleen cathepsin C	Bos taurus	3		single protein format	Scientific Literature
7.	ALA1816176	B	Inhibition of Flavobacterium sp. prolyl endopeptidase	Flavobacterium	3		assay format	Scientific Literature
8.	ALA1816177	B	Inhibition of Bacillus sp. proline iminopeptidase	Bacillus	3		assay format	Scientific Literature
9.	ALA1816178	B	Inhibition of porcine kidney leucine aminopeptidase	Sus scrofa	3		assay format	Scientific Literature
10.	ALA1816179	F	Hypoglycemic activity in female Wistar fatty rat type 2 diabetic model assessed as reduction of plasma glucose level at 1 mg/kg, po by oral glucose tolerance test	Rattus norvegicus	2		organism-based format	Scientific Literature
11.	ALA1816180	F	Hypoglycemic activity in orally dosed female Wistar fatty rat type 2 diabetic model assessed as reduction of plasma glucose level by oral glucose tolerance test	Rattus norvegicus	1		organism-based format	Scientific Literature